Atypical Teratoid/Rhabdoid Tumor
Oncology·MeSH: Rhabdoid Tumor
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Tiragolumab | ENANTA PHARMACEUTICALS INC (ENTA) |
Frequently asked questions
How many drugs are in development for Atypical Teratoid/Rhabdoid Tumor?
BioSniper tracks 1 drug in development for Atypical Teratoid/Rhabdoid Tumor across 1 company.
How many clinical trials target Atypical Teratoid/Rhabdoid Tumor?
There are 2 clinical trials targeting Atypical Teratoid/Rhabdoid Tumor tracked by BioSniper.
Deep-dive into Atypical Teratoid/Rhabdoid Tumor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis